Bioabsorbable stents market seen reaching $0.65 billion by 2030

The Business Research Company says the bioabsorbable stents market is set to grow from $0.41 billion in 2025 to $0.65 billion by 2030 as cardiovascular disease, heart failure and an aging population drive demand. The report points to North America as the largest regional market in 2025 and highlights new materials, polymer-based stents and regulatory approvals as key trends.

Why it matters: - Bioabsorbable stents are designed to open blocked blood vessels and then dissolve, which can reduce the risk of long-term complications from permanent implants. - The market’s growth signals rising demand for temporary vascular support devices as cardiovascular disease treatment expands. - The report ties demand to heart failure, a condition that affects 750,000 people in Canada and adds an estimated $2.8 billion in annual healthcare costs there by 2030.

What happened: - The Business Research Company released its Bioabsorbable Stents Market Report 2026, covering market size, trends and a global forecast for 2026-2035. - The market is projected to rise from $0.41 billion in 2025 to $0.45 billion in 2026, a 10.3% CAGR. - The report forecasts the market will reach $0.65 billion by 2030, at a 9.5% CAGR. - North America held the largest market share in 2025, with Western Europe next.

The details: - Growth through 2026 reflects higher cardiovascular disease prevalence, wider use of interventional cardiology procedures, early adoption of biodegradable polymers in implants, more coronary stent procedures and advances in vascular intervention techniques. - The report says future growth will be supported by demand for temporary vascular support devices, a stronger focus on long-term patient outcomes, more treatment for peripheral artery disease, higher research spending on biodegradable implants and more regulatory approvals for novel stent materials. - Key trends include next-generation bioabsorbable materials, greater adoption of polymer-based stents, more emphasis on lowering long-term complications, more clinical trials in peripheral applications, and tighter focus on biocompatibility and patient safety. - The report also defines bioabsorbable stents as tubular devices placed in blood vessels to restore blood flow and then gradually dissolve. - The report covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa in addition to North America and Western Europe. - The Business Research Company also says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample report is available here. - The full report is available here.

Between the lines: - The forecast suggests bioabsorbable stents are moving from a niche implant category toward broader cardiovascular use cases. - The emphasis on dissolvable materials points to an industry push to balance short-term vessel support with fewer long-term device risks. - The inclusion of peripheral artery disease and clinical trials outside coronary use suggests the market may broaden beyond its core applications.

What's next: - More regulatory approvals for new stent materials could shape the pace of commercialization. - Continued research in biodegradable implants and clinical testing in peripheral applications will likely influence which materials and products gain traction. - Regional competition may widen as Asia-Pacific and other markets build on the early lead of North America and Western Europe.

The bottom line: - Bioabsorbable stents are gaining momentum as aging populations, heart failure and cardiovascular disease keep pushing demand for temporary, lower-risk vascular devices.